Security key
87961M105
Telix Pharmaceuticals Ltd - Ordinary Shares (TLX)
CUSIP: 87961M105
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Ordinary Shares
- Total 13F shares
- 452,466
- Total 13F value
- $7,285,409
- Share change
- +404,819
- SEC-reported price per share
- $16.07
- Number of holders
- 21
- Value change
- +$6,501,020
- Number of buys
- 19
- Number of sells
- 3
- Shares outstanding
- 334,705,968
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
21
Top holders
10
TLX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Telix Pharmaceuticals Ltd SEC filings
Telix Pharmaceuticals Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87961M105
Recent filing periods:
Ownership snapshot
Top reported holders of TLX - Telix Pharmaceuticals Ltd - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Behrenbruch Christian
Disclosed value leader
Behrenbruch Christian
Comparable rows
8/8
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 7%
13D/G row: Behrenbruch Christian
Showing 1-6 of 8 holder rows.
Quick read
Behrenbruch Christian leads the comparable SEC ownership view at 7%.
8 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Behrenbruch Christian's linked filing trail.
Comparable ownership
Top 5
Behrenbruch Christian
7%
Kluge Andreas
6.8%
ABC ARBITRAGE SA
0.01%
Private Advisor Group, LLC
0%
MORGAN STANLEY
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Behrenbruch Christian |
13D/G
|
7%
|
$404,991,544
23,329,006 shares
|
$0 | 12 Nov 2024 |
| Kluge Andreas |
13D/G
|
6.8%
|
$393,638,000
22,675,000 shares
|
$0 | 12 Nov 2024 |
| ABC ARBITRAGE SA |
13F
Company
|
0.01%
|
$451,498
26,939 shares
|
— | 31 Mar 2025 |
| Private Advisor Group, LLC |
13F
Company
|
0%
|
$169,946
10,140 shares
|
— | 31 Mar 2025 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$94,426
5,634 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
0%
|
$61,191
3,651 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
452,466
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2026 Across Filers
Q1 2026 holders
38
Q2 2025 holders
21
Holder diff
-17
| Investor | Q1 2026 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend